Real-time Estimate
Other stock markets
|
5-day change | 1st Jan Change | ||
7.45 USD | -1.59% | -1.59% | -11.97% |
Apr. 02 | Voyager Therapeutics, Inc. Appoints Robin Swartz as Principal Accounting Officer | CI |
Apr. 02 | Voyager Therapeutics, Inc. Announces CFO Changes | CI |
Financials (USD)
Sales 2024 * | 38.84M | Sales 2025 * | 51.19M | Capitalization | 411M |
---|---|---|---|---|---|
Net income 2024 * | -98M | Net income 2025 * | -106M | EV / Sales 2024 * | 2.44 x |
Net cash position 2024 * | 316M | Net cash position 2025 * | 373M | EV / Sales 2025 * | 0.74 x |
P/E ratio 2024 * |
-4.21
x | P/E ratio 2025 * |
-4.31
x | Employees | 162 |
Yield 2024 * |
-
| Yield 2025 * |
-
| Free-Float | 82.71% |
Latest transcript on Voyager Therapeutics, Inc.
1 day | -1.05% | ||
1 week | -2.20% | ||
Current month | -18.69% | ||
1 month | -15.98% | ||
3 months | +1.47% | ||
6 months | +9.87% | ||
Current year | -10.31% |
Managers | Title | Age | Since |
---|---|---|---|
Alfred Sandrock
CEO | Chief Executive Officer | 67 | 22-02-28 |
Michael Higgins
CHM | Chairman | 61 | 15-07-21 |
Director of Finance/CFO | 55 | 22-09-18 |
Members of the board | Title | Age | Since |
---|---|---|---|
George Scangos
BRD | Director/Board Member | 76 | 23-05-08 |
James Geraghty
BRD | Director/Board Member | 70 | 13-12-31 |
Glenn F. Pierce
BRD | Director/Board Member | 68 | 17-01-04 |
Name | Weight | AuM | 1st Jan change | Investor Rating |
---|---|---|---|---|
0.05% | 2 M€ | -.--% | ||
0.01% | 0 M€ | 0.00% | - | |
0.00% | 34 M€ | +2.35% | - |
Date | Price | Change | Volume |
---|---|---|---|
24-04-25 | 7.47 | -1.32% | 207 104 |
24-04-24 | 7.57 | -1.05% | 312,899 |
24-04-23 | 7.65 | +1.06% | 372,355 |
24-04-22 | 7.57 | +0.93% | 324,119 |
24-04-19 | 7.5 | -0.66% | 516,459 |
Delayed Quote Nasdaq, April 24, 2024 at 04:00 pm EDT
More quotesEPS Revisions
1st Jan change | Capi. | |
---|---|---|
-10.31% | 411M | |
+4.09% | 43.84B | |
+46.90% | 41.25B | |
+9.45% | 41.68B | |
-10.92% | 27.04B | |
+9.32% | 25.53B | |
-24.87% | 18.18B | |
+29.70% | 12.29B | |
+1.28% | 12.29B | |
+7.78% | 11.15B |
- Stock Market
- Equities
- VYGR Stock